JPRN-UMIN000015951已完成1 期
1st line chemotherapy of XELoda/OXaliplatin for advanced Gastric cancer PI - G-XELOX PI study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) active synchronous or metachronous malignancy other than carcinoma in situ 2) pregnant or nursing 3) severe mental disorders 4) systemic steroid user 5) diabetes mellitus, uncontrolled or controlled with insulin 6) history of myocardial infarction, unstable angina within 3 months prior to the registration 7) serious coexisting illness 8) active infection 9) peripheral neuropathy greater than Grade 2 10) ileus 11) massive pleural effusion or ascites
研究者
相似试验
已完成
1 期
eoadjuvant chemotherapy of XELOda/OXaliplatin for locally advanced Gastric cancer PIgastric cancerJPRN-UMIN000015950Kobe City Medical Center General Hospital9
已完成
2 期
A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.Nasopharyngeal CancerNCT00439426Hoffmann-La Roche25
已完成
不适用
eoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PIIgastric cancerJPRN-UMIN000018661Kobe City Medical Center General Hospital40
已完成
1 期
eoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PIgastric cancerJPRN-UMIN000015181Kobe City Medical Center General Hospital9
已完成
2 期
Treatment using Oxaliplatin and S-1 Adjuvant chemotherapy for Stage III gastric cancer trialGastric cancerJPRN-UMIN000025824Department of Surgery, Kochi Medical School75